Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Bluebird Bio

Bluebird Bio reported $3.38M in Cost of Sales for its fiscal quarter ending in March of 2023.

Cost Of Sales Change
Agios Pharmaceuticals AGIO:US USD 554K 141K
Alnylam Pharmaceuticals ALNY:US USD 54.87M 3.6M
Amgen AMGN:US USD 1.68B 65M
Biogen BIIB:US USD 662.8M 91.9M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bluebird Bio BLUE:US USD 3.38M 3.36M
Gilead Sciences GILD:US USD 1.4B 5M
Immunogen IMGN:US USD 626K 450K
Incyte Corp INCY:US USD 51.42M 2.34M
Intercept Pharmaceuticals ICPT:US USD 222K 194K
Ionis Pharmaceuticals IONS:US USD 1.34M 2.34M
Mirati Therapeutics MRTX:US USD 817K 217K
Moderna Inc MRNA:US USD 792M 1.13B
Nektar Therapeutics NKTR:US USD 7.06M 827K
Novartis NOVN:VX USD 3.83B 8M
Pfizer PFE:US USD 5.03B 4.8B
PTC Therapeutics PTCT:US USD 14.14M 3.25M
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Sarepta Therapeutics SRPT:US USD 35.02M 4.22M
Seattle Genetics SGEN:US USD 111.78M 3.57M
Ultragenyx Pharmaceutical RARE:US USD 12.26M 6.94M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M